The blood test is capable of detecting 50 cancer types and subtypes, including the ones considered most deadly, like pancreatic, ovarian, liver, esophageal, lung, and stomach cancers. Currently, it’s ...

Last month, University College London Hospitals announced a new test for women at high risk of ovarian cancer due to ...

Tumor markers for small cell lung cancer (SCLC) are measurable using blood tests, such as neuron-specific enolase (NSE). They can support the identification and management of cancer. Doctors use a ...

Importantly, stomach cancer is also being diagnosed in an increasing number of younger people -- that is, those younger than 50. In 2019, these cancers -- also called early-onset -- accounted for ...

Testing lung cancer patients for tumor markers would enable doctors to choose which drug the patient is most likely to respond to, improving the chances for successful treatment, according to results ...

(San Diego, CA) August 21, 2009 – GenWay Clinical Laboratory, a US-based diagnostic company with CLIA certification, has validated a general tumor marker test in their laboratory and now offers this ...

Tumor markers can help doctors diagnose testicular cancer, determine effective treatment, and monitor how well that treatment is working. Doctors have been using tumor markers to help diagnose and ...

The initial treatment for all testicular cancer is the radical inguinal orchiectomy. After this surgery, stage 1 patients have three main approaches for managing the low risk of recurrence. The best ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

In the article that accompanies this editorial, Ramsey et al 1 report the results of their study on tumor marker use among older women with early-stage breast cancer. The study is a Seer-Medicare ...

Consumer genetics company 23andMe scored FDA 510(k) clearance for a test to detect a hereditary marker for prostate cancer. The risk report provides information on whether users have the G84E mutation ...

A cancer survivor describes the emotional rollercoaster of learning her tumor marker levels have risen. "I had decided that this would be the year I would bid farewell to my cancer journey. So much ...